FA
RDY icon

FDx Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

FDx Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-60,780
Closed -$563K – 941
2015
Q4 		$563K Buy
60,780
+705
+1% +$7.72K 0.03% 523
2015
Q3 		$768K Sell
60,075
-52,430
-47% -$651K 0.07% 326
2015
Q2 		$1.25M Buy
112,505
+46,505
+70% +$513K 0.06% 279
2015
Q1 		$753K Sell
66,000
-2,745
-4% -$29.1K 0.02% 726
2014
Q4 		$694K Buy
68,745
+6,540
+11% +$68.8K 0.04% 427
2014
Q3 		$654K Buy
62,205
+17,620
+40% +$166K 0.04% 472
2014
Q2 		$385K Buy
+44,585
New +$375K 0.03% 688

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

FDx Advisors's RDY Position: Q1 2016 in Review

FDx Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q1 2016, closing a stake of 60,780 shares — an estimated $563K sold.

FDx Advisors first reported a position in RDY in Q2 2014 and held it in 7 quarters. The position peaked at $1.25M in Q2 2015. 160 funds tracked by Wall St. Rank hold RDY as of Q1 2016.

  • FDx Advisors reported no remaining Dr. Reddy's Laboratories position as of Q1 2016 after selling out during the quarter.
  • FDx Advisors sold 60,780 Dr. Reddy's Laboratories shares in Q1 2016, an estimated $563K.
  • FDx Advisors first reported a position in Dr. Reddy's Laboratories in Q2 2014 and held it in 7 quarters.
  • FDx Advisors's Dr. Reddy's Laboratories position peaked at $1.25M in Q2 2015.
  • 160 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2016.

Based on FDx Advisors's 13F filing for Q1 2016, filed 17 May 2016.